The hyper-endemic prevalence of hepatitis E in various economies across the world, specifically in Asia Pacific, is likely to boost the need for hepatitis E diagnostic tests, globally in the coming years. The global hepatitis E diagnostic tests market, which was valued at US$43.7 mn in 2015, is projected to expand at a CAGR of 3.80% between 2016 and 2024 and rise to an opportunity worth US$60.4 mn by 2024.
This 162 page report gives readers a comprehensive overview of the Hepatitis E Diagnostic Tests Market. Browse through 18 data tables and 55 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/hepatitis-e-diagnostic-tests-market.html
ELISA HEV IgM test kits, ELISA HEV IgG test kits, and RT-PCR test kits are the main types of test kits available in the global hepatitis E diagnostic test market. Since ELISA HEV IgM test kits are utilized extensively in the primary tests for the diagnosis of hepatitis E infections, these kits have been registering a higher demand than other test kits. Supported by the growing seroprevalence of hepatitis E across the world, researchers expect the demand for ELISA HEV IgM test kits to continue to rise remarkably over the forecast period.
The RT-PCR test kits segment is likely to follow the ELISA HEV IgM test kits segment closely in the coming years. As RT-PCR test is considered as the direct test for the diagnosis of acute infections of hepatitis E, the demand for RT-PCR test kits is also expected to increase substantially in near future. On the flip side, the ELISA HEV IgG test kits segment is projected to report a modest progression over the years to come.
Get accurate market forecast and analysis on the Hepatitis E Diagnostic Tests Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16859
On the basis of geography, the global market for hepatitis E diagnostic tests is segmented into Europe, Asia Pacific, Latin America, North America, and the Middle East and Africa. In 2015, Asia Pacific led the worldwide market with a share of more than 42% and is projected to remain dominant over the forecast period. A number of Asian countries, such as India, Nepal, Pakistan, Bangladesh, Bhutan, Vietnam, Kazakhstan, Thailand, and Burma, suffer from hyperendemicity of hepatitis E, which leads to an increased need for hepatitis E diagnostic tests, supporting the growth of the Asia Pacific market.
Apart from this, the Middle East and Africa will also witness a prominent rise in the market for the hepatitis E diagnostic tests in the coming years on account of the growing prevalence of hepatitis E in several economies, such as Uganda, Kenya, Morocco, and Nigeria due to poor sanitation facilities and lack of safe drinking water. On the other hand, the markets in North America and Europe will not report any noteworthy growth in the near future due to the insignificant prevalence of hepatitis E.
Some of the leading companies in the global market for hepatitis E diagnostic tests are Primerdesign Ltd., MP Biomedicals LLC, Mikrogen GmBH, Fortress Diagnostics Ltd., Fast-track diagnostics Ltd., F. Hoffmann-La Roche Ltd., Dia.Pro – Diagnostic Bioprobes s.r.l, Biokit S.A., Beijing Wantai Biological Pharmacy, and Altana Diagnostics GmbH.
Transparency Market Research
90 State Street,
NY – 12207
USA – Canada Toll Free 866-552-3453